Mounjaro vs. Wegovy: Head-to-Head Trial Results

Mounjaro led to a 20% weight reduction after 72 weeks, compared to Wegovy's 14%. Why this matters: This difference could be significant for individuals needing to lose substantial weight.

32% of participants on Mounjaro lost a quarter of their body weight, versus 16% on Wegovy. Why this matters: Demonstrates Mounjaro may offer more aggressive weight loss for some.

Mounjaro users experienced an average waistline reduction of 18cm, compared to 13cm with Wegovy. Why this matters: Waist circumference is a key indicator of metabolic health.

Participants on Mounjaro showed better blood pressure, blood sugar, and cholesterol levels. Why this matters: Highlights potential benefits beyond just weight loss.

Both drugs have similar levels of side effects. Why this matters: Suggests the choice between the two can be driven by efficacy rather than tolerability.

Consult with a healthcare provider to determine if weight loss drugs are appropriate for you.

Understand potential side effects and long-term implications.

Combine medication with lifestyle changes, including diet and exercise, for optimal results.

Individuals with obesity or related health conditions like diabetes and heart disease.

Those who have struggled to lose weight through diet and exercise alone.

Q: How do Mounjaro and Wegovy work?

Q: Are there any risks associated with these drugs?

Mounjaro appears to be more effective for weight loss than Wegovy, based on trial results.

Both drugs can significantly reduce weight and improve metabolic health.

The choice between Mounjaro and Wegovy should be made in consultation with a healthcare professional, considering individual needs and health status.